Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

New melanogenesis inhibitor isolated from actinomycete

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

MedImmune seeks FDA approval for psoriasis trials with MEDI-507

Nov. 28, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

New histamine antagonists described for dermatological indications

Nov. 21, 1997

Phase II begins for psoriasis vaccine

Nov. 20, 1997

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

Cellegy to acquire nitroglycerin-based product for anorectal conditions

Nov. 6, 1997

KGF fragments from Chiron display wound-healing activity

Nov. 5, 1997

Lifecore reaches patient enrollment milestone in Intergel study

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.